Since its delineation in the early 1970s, it has become apparent that inclusion body myositis (IBM) is the most commonly-acquired myopathy in middle-aged and older people. Although classified as one of the inflammatory myopathies, with polymyositis and dermatomyositis, several features set it apart, not least its resistance to immunosuppressant therapies. The diagnosis may be strongly suspected on the basis of clinical features alone, but confirmation is by the demonstration, in a muscle biopsy specimen, of characteristic light and electron microscopic changes
Most cases present after the age of 50 years. IBM is substantially commoner in men, by at least 5 : 1. The overall incidence is in the order of 1/100 000 population/annum.
Patients typically present with symptoms relating to quadriceps weakness (Figs 1–3): ‘knees giving-way’, difficulty in rising from a chair and squatting. Observers may comment on quadriceps atrophy. It is the most common cause
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- Inclusion body myositis: old and new concepts
- Evaluation and treatment of inflammatory myopathies
- Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis
- DIAGNOSIS AND TREATMENT OF INFLAMMATORY MUSCLE DISEASES
- A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis
- Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features
- Proximal myopathy: diagnostic approach and initial management
- Immunoglobulin therapy in inflammatory myopathies
- Coexistence of TDP-43 and C5b-9 staining of muscle in a patient with inclusion body myositis
- Muscle disease